Allurion Technologies company info

What does Allurion Technologies do?
Allurion Technologies (NYSE:ALRN) focuses on innovative medical technologies that aim to tackle obesity and its associated health issues. As of now, the company is only listed on the New York Stock Exchange under the ticker symbol NYSE:ALRN, making it accessible to investors interested in the healthcare and technology sectors. Allurion is known for its flagship product, the Allurion Balloon, which is a swallowable and self-expelling gastric balloon that aids in weight loss without the need for surgery. By offering a non-surgical alternative, Allurion aims to revolutionize the approach to weight management and improve the quality of life for individuals struggling with obesity. The company's objectives revolve around expanding access to its technology globally while continuing to innovate in the field of non-invasive medical solutions for weight loss and beyond.
Allurion Technologies company media
Company Snapshot

Is Allurion Technologies a public or private company?

key
Ownership
Public

How many people does Allurion Technologies employ?

people
Employees
503

What sector is Allurion Technologies in?

pie chart
Sector
Consumer Discretionary

Where is the head office for Allurion Technologies?

location pin
Head Office
Natick, United States

What year was Allurion Technologies founded?

founded flag
Year Founded
2009
What does Allurion Technologies specialise in?
/Weight Loss /Gastric Balloons /Non-Surgical Procedure /Elipse Program /Healthcare Innovation /Obesity Treatment

What are the products and/or services of Allurion Technologies?

Overview of Allurion Technologies offerings
The Allurion Balloon, a swallowable, non-surgical weight loss device that resides in the stomach to create a feeling of fullness.
A connected digital health platform offering nutritional and lifestyle coaching to support weight loss.
The Allurion Program, a comprehensive weight loss program integrating the balloon with personalized, professional health coaching.
A mobile app for patients to track their weight loss journey, meal plans, and physical activity, enhancing the effectiveness of the weight loss balloon.
Non-invasive gastric balloon removal tools, ensuring a safe and comfortable end to the balloon's life cycle.
Advanced research and development into next-generation materials and designs to improve efficacy and patient experience in non-surgical weight loss solutions.

Who is in the executive team of Allurion Technologies?

Allurion Technologies leadership team
  • Dr. Shantanu K. Gaur M.D.
    Dr. Shantanu K. Gaur M.D.
    Co-Founder, CEO, President & Director
  • Dr. Samuel G. Levy
    Dr. Samuel G. Levy
    Co-Founder
  • Mr. Christopher  Geberth
    Mr. Christopher Geberth
    CFO & Treasurer
  • Dr. Ram  Chuttani M.D.
    Dr. Ram Chuttani M.D.
    MD, Chief Medical Officer & Founding Partner
  • Mr. Brendan Michael Gibbons
    Mr. Brendan Michael Gibbons
    Chief Legal Officer & Corporate Secretary
  • Matt  Wright
    Matt Wright
    Vice President of People
  • Ms. Joyce  Johnson
    Ms. Joyce Johnson
    Senior Vice President of RA & QA